|Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: a double-blind, randomized, controlled trial|
M Jafarinia, M Afarideh, A Tafakhori, M Arbabi, A Ghajar, AA Noorbala, ...
Journal of affective disorders 204, 1-8, 2016
|An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic …|
A Alamdari, R Mozafari, A Tafakhori, S Faghihi-Kashani, N Hafezi-Nejad, ...
Neurological Sciences 36 (7), 1121-1126, 2015
|A clinical and molecular genetic study of 50 families with autosomal recessive parkinsonism revealed known and novel gene mutations|
S Taghavi, R Chaouni, A Tafakhori, LJ Azcona, SG Firouzabadi, ...
Molecular neurobiology 55 (4), 3477-3489, 2018
|Early versus late spinal decompression surgery in treatment of traumatic spinal cord injuries; a systematic review and meta-analysis|
M Yousefifard, V Rahimi-Movaghar, M Baikpour, P Ghelichkhani, ...
Emergency 5 (1), 2017
|Effects of early intervention of swallowing therapy on recovery from dysphagia following stroke|
J Bakhtiyari, P Sarraf, N Nakhostin-Ansari, A Tafakhori, J Logemann, ...
Iranian journal of neurology 14 (3), 119, 2015
|The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients|
M Abdolahi, A Tafakhori, M Togha, AA Okhovat, F Siassi, MR Eshraghian, ...
Immunogenetics 69 (6), 371-378, 2017
|Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial|
M Ahmadi, E Agah, S Nafissi, MR Jaafari, MH Harirchian, P Sarraf, ...
Neurotherapeutics 15 (2), 430-438, 2018
|Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis|
E Agah, A Zardoui, A Saghazadeh, M Ahmadi, A Tafakhori, N Rezaei
PloS one 13 (1), e0190252, 2018
|Memantine for prophylactic treatment of migraine without aura: A randomized double‐blind placebo‐controlled study|
R Noruzzadeh, A Modabbernia, V Aghamollaii, M Ghaffarpour, ...
Headache: The Journal of Head and Face Pain 56 (1), 95-103, 2016
|A novel combination of ω-3 fatty acids and nano-curcumin modulates interleukin-6 gene expression and high sensitivity C-reactive protein serum levels in patients with migraine …|
M Abdolahi, P Sarraf, MH Javanbakht, NM Honarvar, M Hatami, N Soveyd, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2018
|Sensing of Alzheimer’s disease and multiple sclerosis using nano-bio interfaces|
MJ Hajipour, F Ghasemi, H Aghaverdi, M Raoufi, U Linne, F Atyabi, ...
Journal of Alzheimer's Disease 59 (4), 1187-1202, 2017
|Identification of a Large DNAJB2 Deletion in a Family with Spinal Muscular Atrophy and Parkinsonism|
E Sanchez, H Darvish, R Mesias, S Taghavi, SG Firouzabadi, RH Walker, ...
Human mutation 37 (11), 1180-1189, 2016
|Serum and CSF PDGF‐AA and FGF‐2 in relapsing‐remitting multiple sclerosis: a case–control study|
MH Harirchian, AH Tekieh, A Modabbernia, V Aghamollaii, A Tafakhori, ...
European Journal of Neurology, 2012
|Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial|
S Arabzadeh, E Hakkikazazi, N Shahmansouri, A Tafakhori, A Ghajar, ...
Journal of affective disorders 235, 236-241, 2018
|The combined effects of ω-3 fatty acids and nano-curcumin supplementation on intercellular adhesion molecule-1 (ICAM-1) gene expression and serum levels in migraine patients|
N Soveyd, M Abdolahi, M Djalali, M Hatami, A Tafakhori, P Sarraf, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017
|Validation of the Persian version of the Brief Pain Inventory (BPI-P) in chronic pain patients|
H Majedi, SS Dehghani, S Soleyman-Jahi, SAE Meibodi, ...
Journal of pain and symptom management 54 (1), 132-138. e2, 2017
|EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature|
A Nejati, Z Shoja, S Shahmahmoodi, A Tafakhori, Y Mollaei-Kandelous, ...
Medical microbiology and immunology 205 (2), 143-154, 2016
|Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson's disease in Iranian population|
L Haghnejad, B Emamalizadeh, J Jamshidi, AZ Bidoki, H Ghaedi, ...
Journal of the neurological sciences 355 (1-2), 72-74, 2015
|Transplantation of olfactory ensheathing cells on functional recovery and neuropathic pain after spinal cord injury; systematic review and meta-analysis|
B Nakhjavan-Shahraki, M Yousefifard, V Rahimi-Movaghar, M Baikpour, ...
Scientific reports 8 (1), 1-12, 2018
|Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease versus other progressive movement disorders|
B Fallahi, A Esmaeili, D Beiki, S Oveisgharan, H Noorollahi-Moghaddam, ...
Annals of nuclear medicine 30 (2), 153-162, 2016